Doctor profile · Federal record
Dr. ROBERT COPPOLA, DO
Neurology Physician (CMS: NEUROLOGY) · Student in an Organized Health Care Education/Training Program · MIAMI, FL
- NPI 1518405463
- Accepts Medicare
- 9 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
7374 SW 93RD AVE
MIAMI, FL 331735201
(786) 753-7467 - Additional location
-
7031 SW 62nd Ave
South Miami, FL 331434701
(954) 249-8759 - Mailing address
-
7031 SW 62ND AVE
SOUTH MIAMI, FL 331434701
Credentials & registration
- NPI registered
- February 2017 — 9 yrs on file
- Profile last updated
- June 22, 2020
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Florida #OS16607
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518405463. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
928
Distinct HCPCS
8
Medicare allowed
$172,149
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
96116 |
Exam of neurobehavioral status, first hour | 186 | 167 | $93 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 181 | 120 | $180 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 159 | 116 | $129 | |
95819 |
Measurement of brain wave activity (eeg), awake and asleep | 145 | 144 | $442 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 117 | 117 | $171 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 62 | 62 | $226 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 51 | 32 | $33 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 27 | 25 | $73 |
In context: peer comparison
Among 53 peers in this city , average services per provider: 382. This provider delivers 2.4× the peer median.Open Payments
Industry payments received
All-time total
$43,031
Transactions
148
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Biogen, Inc. | 36 | $20,811.85 | |
| TG Therapeutics, Inc. | 14 | $13,426.90 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $4,335.00 | |
| MDD US Operations, LLC | 4 | $744.34 | |
| EMD Serono, Inc. | 23 | $728.61 | |
| Alexion Pharmaceuticals, Inc. | 11 | $458.84 | |
| Celgene Corporation | 5 | $364.70 | |
| GENZYME CORPORATION | 4 | $356.51 | |
| Novartis Pharmaceuticals Corporation | 20 | $321.82 | |
| Lundbeck LLC | 8 | $226.22 | |
| Otsuka America Pharmaceutical, Inc. | 6 | $205.73 | |
| SI-BONE, INC. | 1 | $158.27 | |
| Teva Pharmaceuticals USA, Inc. | 2 | $116.09 | |
| Genentech USA, Inc. | 5 | $109.38 | |
| Neurelis, Inc. | 6 | $101.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
396
Patients
98
Total drug cost
$463,103
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 63 | 23 | $1,047 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 56 | 19 | $2,410 |
| Donepezil Hcl | Generic | 52 | 20 | $563 |
| Baclofen | Generic | 49 | 14 | $1,976 |
| Clonazepam | Generic | 24 | 0 | $196 |
| Kesimpta Pen (Ofatumumab) | Brand | 22 | 0 | $252,749 |
| Memantine Hcl | Generic | 18 | 0 | $941 |
| Duloxetine Hcl | Generic | 17 | 0 | $366 |
| Diazepam | Generic | 16 | 11 | $59 |
| Tizanidine Hcl | Generic | 15 | 11 | $142 |